Effects of preoperative octreotide treatment on different subtypes of 90 GH-secreting pituitary adenomas and outcome in one surgical centre

SMS 201–995: A very potent and selective octapeptide analogue of somatostatin with prolonged action

1982 • 1,317 citations

Pituitary Adenomas with Invasion of the Cavernous Sinus Space

1993 • 1,089 citations

Octreotide Treatment of Acromegaly

1992 • 270 citations

Safety and efficacy of long-term octreotide therapy of acromegaly: results of a multicenter trial in 103 patients--a clinical research center study.

1995 • 246 citations

Octreotide as Primary Therapy for Acromegaly

1998 • 243 citations

Long-term Treatment of 189 Acromegalic Patients With the Somatostatin Analog Octreotide

1991 • 234 citations

Effect of Octreotide Pretreatment on Surgical Outcome in Acromegaly

1997 • 214 citations

Preoperative Treatment of Acromegaly with Long-Acting Somatostatin Analog SMS 201-995: Shrinkage of Invasive Pituitary Macroadenomas and Improved Surgical Remission Rate*

1988 • 191 citations

Clinical review 75: Recent advances in pathogenesis, diagnosis, and management of acromegaly.

1995 • 188 citations

Presurgical octreotide treatment in acromegaly

1992 • 148 citations

Long‐term therapy with long‐acting octreotide (Sandostatin‐LAR^®) for the management of acromegaly

1998 • 139 citations

Direct Postoperative and Follow-Up Results of Transsphenoidal Surgery in 19 Acromegalic Patients Pretreated with Octreotide Compared to Those in Untreated Matched Controls

1999 • 102 citations

Sandostatin LAR®: Pharmacokinetics, pharmacodynamics, efficacy, and tolerability in acromegalic patients

1995 • 90 citations

Does Octreotide Treatment Improve the Surgical Results of Macro-Adenomas in Acromegaly? A Randomized Study

1999 • 88 citations

Sandostatin LAR in acromegalic patients: a dose-range study.

1995 • 66 citations

Treatment of invasive growth hormone pituitary adenomas with long-acting somatostatin analog SMS 201–995 before transsphenoidal surgery

1994 • 56 citations

Pre-operative treatment of 5 acromegalics with a somatostatin analogue: endocrine and clinical observations

1987 • 46 citations

Recent primary transnasal surgical outcomes associated with intraoperative growth hormone measurement in acromegaly

1999 • 45 citations

Recent Results of Secondary Transnasal Surgery for Residual or Recurring Acromegaly

1998 • 43 citations

CLINICAL AND BIOCHEMICAL EFFECTS OF INCREMENTAL DOSES OF THE LONG‐ACTING SOMATOSTATIN ANALOGUE SMS 201‐995 IN TEN ACROMEGALIC PATIENTS

1990 • 35 citations

Reversible Shrinkage of a Growth Hormone-Secreting Pituitary Adenoma by a Long-Acting Somatostatin Analogue, Octreotide

1989 • 31 citations

Pressure-irrigation-suction system technical note

1982 • 30 citations

Acromegaly—the place of the neurosurgeon

1996 • 27 citations

Effects of Octreotide on Morphology of Pituitary Adenomas in Acromegaly

1993 • 13 citations

Value of transcavernous surgery in the treatment of pituitary adenomas

1995 • 9 citations

A Multicenter Clinical Trial of SMS 201-995 (octreotide acetate) in Acromegaly and Gigantism

1989 • 6 citations